ATE169217T1 - Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten - Google Patents
Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheitenInfo
- Publication number
- ATE169217T1 ATE169217T1 AT92810726T AT92810726T ATE169217T1 AT E169217 T1 ATE169217 T1 AT E169217T1 AT 92810726 T AT92810726 T AT 92810726T AT 92810726 T AT92810726 T AT 92810726T AT E169217 T1 ATE169217 T1 AT E169217T1
- Authority
- AT
- Austria
- Prior art keywords
- autoimmune diseases
- prevent
- hydrogen
- alkyl group
- treat autoimmune
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- 150000002241 furanones Chemical class 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000004696 coordination complex Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27654391 | 1991-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE169217T1 true ATE169217T1 (de) | 1998-08-15 |
Family
ID=17570946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92810726T ATE169217T1 (de) | 1991-09-26 | 1992-09-23 | Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US5376682A (de) |
| EP (1) | EP0534907B1 (de) |
| AT (1) | ATE169217T1 (de) |
| DE (1) | DE69226487T2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7636894A (en) * | 1993-09-17 | 1995-04-03 | Upjohn Company, The | Substituted tetronic acids useful for treating hiv and other retroviruses |
| PT817786E (pt) * | 1995-03-20 | 2003-06-30 | Upjohn Co | Acidos tetronicos substituidos uteis para o tratamento do vih e de outros retrovirus |
| JP2001508648A (ja) | 1996-11-06 | 2001-07-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 腫瘍壊死因子レセプター放出酵素、酵素を含む組成物、およびその使用方法 |
| US6593456B1 (en) * | 1996-11-06 | 2003-07-15 | The Regents Of The University Of California | Tumor necrosis factor receptor releasing enzyme |
| US20050191661A1 (en) * | 1996-11-06 | 2005-09-01 | Tetsuya Gatanaga | Treatment of inflammatory disease by cleaving TNF receptors |
| WO2004041217A2 (en) | 2002-11-05 | 2004-05-21 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations and method of use |
| US20040119052A1 (en) * | 2002-12-20 | 2004-06-24 | Beavers William Anthony | Process for preparing alpha- and beta- methyl-gamma-butyrolactone and 3-methyltetrahydrofuran |
| WO2005102315A1 (en) | 2004-04-23 | 2005-11-03 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations for pain control |
| US8951992B2 (en) * | 2008-07-18 | 2015-02-10 | Cornell University | Mycobacterium membrane protease as a target for inhibitors of intrabacterial pH homeostasis |
| CN102265154A (zh) | 2008-10-24 | 2011-11-30 | 马格纳化学国际实验室公司 | 用于筛选与rad9选择性相互作用的化合物的方法 |
| US9073884B2 (en) * | 2010-06-04 | 2015-07-07 | The Regents Of The University Of California | Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3232882A1 (de) * | 1982-09-02 | 1984-03-08 | Josef Dipl.-Chem. Dr.Rer.Nat. Klosa | Neues analgetikum |
| US5045564A (en) * | 1988-12-07 | 1991-09-03 | Allergan, Inc. | Anti-inflammatory 2-furanones |
-
1992
- 1992-09-23 AT AT92810726T patent/ATE169217T1/de not_active IP Right Cessation
- 1992-09-23 DE DE69226487T patent/DE69226487T2/de not_active Expired - Fee Related
- 1992-09-23 EP EP92810726A patent/EP0534907B1/de not_active Expired - Lifetime
- 1992-09-25 US US07/950,563 patent/US5376682A/en not_active Expired - Fee Related
-
1994
- 1994-09-08 US US08/301,398 patent/US5532271A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5532271A (en) | 1996-07-02 |
| DE69226487T2 (de) | 1999-02-18 |
| DE69226487D1 (de) | 1998-09-10 |
| EP0534907A1 (de) | 1993-03-31 |
| EP0534907B1 (de) | 1998-08-05 |
| US5376682A (en) | 1994-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69430816D1 (de) | Verwendung von Piperidin-Derivaten in der Behandlung von Schizophrenie | |
| NO981528L (no) | Substituerte imidazoler med antikreft- og cytokininhibitoraktivitet | |
| ES2102154T3 (es) | Inhibicion de trombina. | |
| NO843836L (no) | Terapeutisk aktive sulfamatderivater | |
| GB9202791D0 (en) | Compounds | |
| ATE294577T1 (de) | Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen | |
| DE69125216D1 (de) | Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen | |
| ATE169217T1 (de) | Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten | |
| DE69428325D1 (de) | Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten | |
| NO943874L (no) | Behandling av resistant neoplasma | |
| DE69029693D1 (de) | Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz | |
| ATE180669T1 (de) | Verwendung von pregnanderivaten zur behandlung von tumoren | |
| IL93989A0 (en) | Pharmaceutical compositions comprising heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases | |
| ES2157961T3 (es) | Inhibicion del hirsutismo y la alopecia en mujeres. | |
| EP0831811A4 (de) | Verfahren zur behandlung von mikrobiellen infektionen | |
| BR9708922A (pt) | Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| ATE254919T1 (de) | Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8 | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| DE3889532D1 (de) | Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie. | |
| DE3770481D1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
| EP0301466A3 (en) | Uricosuric composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |